« Modèle:RC » : différence entre les versions
Aller à la navigation
Aller à la recherche
Aucun résumé des modifications |
Aucun résumé des modifications |
||
| (11 versions intermédiaires par le même utilisateur non affichées) | |||
| Ligne 1 : | Ligne 1 : | ||
** [[Les phenéthylamines]] | ** [[Les phenéthylamines]] | ||
*** [[3-FPM (3-Fluorophenmetrazine), effets, risques, témoignages|3-FPM (3-Fluorophenmetrazine)]] | *** [[3-FPM (3-Fluorophenmetrazine), effets, risques, témoignages|3-FPM (3-Fluorophenmetrazine)]] | ||
*** [[4-FA (4-fluoroamphetamine), effets, risques, témoignages|4-FA (4-fluoroamphetamine)]] | *** [[4-FA (4-fluoroamphetamine), effets, risques, témoignages|4-FA (4-fluoroamphetamine)]] | ||
| Ligne 12 : | Ligne 11 : | ||
**** [[2C-D, effets, risques, témoignages|2C-D]] | **** [[2C-D, effets, risques, témoignages|2C-D]] | ||
**** [[Les NBOMe (25I-NBOMe, 25C-NBOMe...)]] | **** [[Les NBOMe (25I-NBOMe, 25C-NBOMe...)]] | ||
***** [[25C (25C-NBOMe), effets, risques, témoignages|25C (25C-NBOMe)]] | |||
**** [[25I (25I-NBOMe), effets, risques, témoignages|25I (25I-NBOMe)]] | |||
*** [[La famille DOx (DOC, DOI, DOM...)]] | *** [[La famille DOx (DOC, DOI, DOM...)]] | ||
**** [[DOB, effets, risques, témoignages|DOB]] | **** [[DOB, effets, risques, témoignages|DOB]] | ||
**** [[DOC, effets, risques, témoignages|DOC]] | **** [[DOC, effets, risques, témoignages|DOC]] | ||
**** [[DOI, effets, risques, témoignages|DOI]] | **** [[DOI, effets, risques, témoignages|DOI]] | ||
*** [[ | *** [[Les benzofuranes]] | ||
**** [[5-APB, effets, risques, témoignages|5-APB]] | **** [[5-APB, effets, risques, témoignages|5-APB]] | ||
**** [[5-MAPB, effets, risques, témoignages|5-MAPB]] | **** [[5-MAPB, effets, risques, témoignages|5-MAPB]] | ||
| Ligne 23 : | Ligne 24 : | ||
**** [[Méphédrone, effets, risques, témoignages|Méphédrone (4-MMC)]] | **** [[Méphédrone, effets, risques, témoignages|Méphédrone (4-MMC)]] | ||
**** [[3-MMC, effets, risques, témoignages|3-MMC]] | **** [[3-MMC, effets, risques, témoignages|3-MMC]] | ||
**** [[3-CMC, effets, risques, témoignages|3-CMC]] | |||
**** [[4-MEC, effets, risques, témoignages|4-MEC]] | **** [[4-MEC, effets, risques, témoignages|4-MEC]] | ||
**** [[Méthylone, effets, risques, témoignages|Méthylone (bk-MDMA)]] | **** [[Méthylone, effets, risques, témoignages|Méthylone (bk-MDMA)]] | ||
**** [[Butylone, effets, risques, témoignages|Butylone (bk-MBDB)]] | **** [[Butylone, effets, risques, témoignages|Butylone (bk-MBDB)]] | ||
**** [[Pentedrone, effets, risques, témoignages|Pentedrone]] | **** [[Pentedrone, effets, risques, témoignages|Pentedrone]] | ||
**** [[N-ethylhexedrone, effets, risques, témoignages|N-ethylhexedrone]] | **** [[N-ethylhexedrone (Hexen), effets, risques, témoignages|N-ethylhexedrone (Hexen)]] | ||
**** [[4-CMC, effets, risques, témoignages|4-CMC]] | |||
**** [[NEP (N-EthylPentedrone), effets, risques, témoignages|NEP (N-EthylPentedrone)]] | |||
**** Les N-Pyrrolidinyl-Cathinones | **** Les N-Pyrrolidinyl-Cathinones | ||
***** [[MDPV, effets, risques, témoignages|MDPV]] | ***** [[MDPV, effets, risques, témoignages|MDPV]] | ||
***** [[a-PVP, effets, risques, témoignages|a-PVP]] | ***** [[a-PVP, effets, risques, témoignages|a-PVP]] | ||
***** [[a-PHP, effets, risques, témoignages|a-PHP]] | |||
***** [[Naphyrone, effets, risques, témoignages|Naphyrone]] | ***** [[Naphyrone, effets, risques, témoignages|Naphyrone]] | ||
*** [[Les phenidates]] | *** [[Les phenidates]] | ||
****[[Ethylphenidate, effets, risques, témoignages|Ethylphenidate]] | |||
****[[Isopropylphénidate, effets, risques, témoignages|Isopropylphénidate]] | ****[[Isopropylphénidate, effets, risques, témoignages|Isopropylphénidate]] | ||
****[[ | ****[[3,4-CTMP (3,4-Dichloromethylphenidate), effets, risques, témoignages|3,4-CTMP (3,4-Dichloromethylphenidate)]] | ||
****[[4F-MPH (4-Fluoromethylphenidate), effets, risques, témoignages|4F-MPH (4-Fluoromethylphenidate)]] | |||
** [[Les tryptamines]] | ** [[Les tryptamines]] | ||
*** [[AMT (alpha-methyltryptamine), effets, risques, témoignages|AMT (alpha-methyltryptamine)]] | *** [[AMT (alpha-methyltryptamine), effets, risques, témoignages|AMT (alpha-methyltryptamine)]] | ||
*** [[5-Meo-Dalt, effets, risques, témoignages|5-Meo-Dalt]] | *** [[5-Meo-Dalt, effets, risques, témoignages|5-Meo-Dalt]] | ||
*** [[5-Meo-DMT, effets, risques, témoignages|5-Meo-DMT]] | |||
*** [[4-AcO-DMT, effets, risques, témoignages|4-AcO-DMT]] | *** [[4-AcO-DMT, effets, risques, témoignages|4-AcO-DMT]] | ||
*** [[Les Lysergamides]] | *** [[Les Lysergamides]] | ||
| Ligne 56 : | Ligne 63 : | ||
*** [[5F-AKB48, effets, risques, témoignages|5F-AKB48]] | *** [[5F-AKB48, effets, risques, témoignages|5F-AKB48]] | ||
*** [[5F-ADB (5F-MDMB-Pinaca), effets, risques, témoignages|5F-ADB (5F-MDMB-Pinaca)]] | *** [[5F-ADB (5F-MDMB-Pinaca), effets, risques, témoignages|5F-ADB (5F-MDMB-Pinaca)]] | ||
*** [[MMB-CHMINACA, effets, risques, témoignages|MMB-CHMINACA]] | |||
*** [[NM-2201, effets, risques, témoignages|NM-2201]] | |||
** [[Methiopropamine, effets, risques, témoignages|Methiopropamine]] | ** [[Methiopropamine, effets, risques, témoignages|Methiopropamine]] | ||
| Ligne 62 : | Ligne 71 : | ||
*** [[U-47700, effets, risques, témoignages|U-47700]] | *** [[U-47700, effets, risques, témoignages|U-47700]] | ||
*** [[AH-7921, effets, risques, témoignages|AH-7921]] | *** [[AH-7921, effets, risques, témoignages|AH-7921]] | ||
** [[Benzodiazépines]] | |||
*** [[Etizolam, effets, risques, témoignages|Etizolam]] | |||
Dernière version du 3 mars 2023 à 18:26
- Les phenéthylamines
- 3-FPM (3-Fluorophenmetrazine)
- 4-FA (4-fluoroamphetamine)
- MDAI
- La famille 2C-x (2C-B, 2C-I, 2C-T-2, 2C-B-Fly...)
- La famille DOx (DOC, DOI, DOM...)
- Les benzofuranes
- Cathinones
- Méphédrone (4-MMC)
- 3-MMC
- 3-CMC
- 4-MEC
- Méthylone (bk-MDMA)
- Butylone (bk-MBDB)
- Pentedrone
- N-ethylhexedrone (Hexen)
- 4-CMC
- NEP (N-EthylPentedrone)
- Les N-Pyrrolidinyl-Cathinones
- Les phenidates
- Les tryptamines
- Les phenéthylamines